Company / AR per Share
IOVANCE BIOTHERAPEUTICS, INC. AR per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.27
FY2025
5-year range
$0.00 / $0.27
FY2023-FY2025
Trend
-0.2%
vs FY2024
Sector context
#79 of 115
Health Care
What the data says
At $0.27, IOVANCE BIOTHERAPEUTICS, INC.'s ar per share ranks #79 of 115 in the Health Care sector. Improved from $0.00 to $0.27 over the past 2 years.
Based on SEC 10-K filings.
0.27 in FY2025.
Improved from $0.00 to $0.27 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#79 of 115 in Health CareTop 69% of 115This company $0.27 Sector average $27.05
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 0.2% year-over-year.
- Ranks #79 out of 115 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | -0.2% |
| FY2024 | $0.27 | +33571.3% |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026